LEMAITRE VASCULAR INC
LEMAITRE VASCULAR INC
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Financial Statements
Values in Millions ($) | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Financial statements beyond 3 years are for subscribers only. Unlock 17+ years of income statements, balance sheets, and cash flow statements Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | |||||||||||||||||
Cash And Cash Equivalents At Carrying Value | 27 | 27 | 28 | 25 | 27 | 25 | 26 | 21 | 22 | 27 | 24 | 18 | |||||
Available For Sale Securities Debt Securities Curr… | 350 | 340 | 331 | 318 | 292 | 277 | 274 | 103 | 91 | 82 | 81 | 79 | |||||
Accounts Receivable Net Current | 36 | 36 | 34 | 32 | 37 | 35 | 30 | 32 | 31 | 30 | 25 | 24 | |||||
Prepaid Expense And Other Assets Current | 6 | 4 | 5 | 6 | 6 | 5 | 7 | 6 | 5 | 4 | 6 | 5 | |||||
Assets Current | 488 | 478 | 468 | 452 | 430 | 408 | 402 | 227 | 213 | 203 | 195 | 182 | |||||
Property Plant And Equipment Net | 30 | 29 | 27 | 26 | 25 | 25 | 25 | 24 | 23 | 22 | 22 | 21 | |||||
Operating Lease Right Of Use Asset | 20 | 20 | 16 | 16 | 17 | 16 | 17 | 17 | 17 | 18 | 18 | 16 | |||||
Goodwill | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | 66 | |||||
Intangible Assets Net Excluding Goodwill | 31 | 32 | 33 | 32 | 33 | 34 | 36 | 37 | 39 | 40 | 42 | 43 | |||||
Deferred Income Tax Assets Net | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | |||||
Other Assets Noncurrent | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | 3 | |||||
Assets | 641 | 630 | 616 | 598 | 578 | 556 | 552 | 377 | 363 | 354 | 347 | 334 | |||||
Liabilities Current | |||||||||||||||||
Accounts Payable Current | 3 | 4 | 4 | 3 | 5 | 2 | 2 | 2 | 2 | 3 | 4 | 4 | |||||
Accrued Liabilities Current | 23 | 25 | 29 | 27 | 23 | 20 | 25 | 23 | 21 | 21 | 24 | 22 | |||||
Operating Lease Liability Current | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 2 | 3 | |||||
Liabilities Current | 30 | 33 | 36 | 33 | 31 | 25 | 31 | 29 | 25 | 27 | 30 | 29 | |||||
Convertible Debt Noncurrent | 169 | 169 | 169 | 168 | 168 | 168 | 168 | - | - | - | 0 | - | |||||
Operating Lease Liability Noncurrent | 18 | 18 | 14 | 14 | 15 | 15 | 15 | 16 | 16 | 16 | 17 | 14 | |||||
Deferred Income Tax Liabilities Net | 2 | 2 | 2 | 2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Other Liabilities Noncurrent | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | |||||
Liabilities | 220 | 223 | 222 | 219 | 215 | 208 | 215 | 46 | 44 | 45 | 49 | 45 | |||||
Stockholders Equity | |||||||||||||||||
Preferred Stock Value | 0 | 0 | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Value | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Additional Paid In Capital Common Stock | 236 | 233 | 228 | 224 | 221 | 217 | 214 | 211 | 209 | 206 | 201 | 198 | |||||
Retained Earnings Accumulated Deficit | 206 | 195 | 185 | 174 | 161 | 152 | 145 | 138 | 130 | 122 | 115 | 110 | |||||
Accumulated Other Comprehensive Income Loss Net Of… | -4 | -4 | -2 | -3 | -3 | -5 | -6 | -3 | -5 | -6 | -5 | -7 | |||||
Treasury Stock Common Value | -18 | -18 | -17 | -16 | -16 | -16 | -16 | -14 | -14 | -14 | - | -13 | |||||
Treasury Stock Value | - | - | - | - | - | - | -16 | - | - | - | -14 | - | |||||
Stockholders Equity | 420 | 407 | 394 | 379 | 363 | 348 | 337 | 331 | 320 | 309 | 298 | 289 | |||||
Liabilities And Stockholders Equity | 641 | 630 | 616 | 598 | 578 | 556 | 552 | 377 | 363 | 354 | 347 | 334 | |||||
Allowance For Doubtful Accounts Receivable Current | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |||||
Preferred Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Preferred Stock Shares Authorized | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | 3 | |||||
Preferred Stock Shares Issued | 0 | 0 | 0 | - | - | - | 0 | - | - | - | - | - | |||||
Preferred Stock Shares Outstanding | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||||
Common Stock Par Or Stated Value Per Share | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | |||||
Common Stock Shares Authorized | 37 | 37 | 37 | 37 | 37 | 37 | 37 | 37 | 37 | 37 | 37 | 37 | |||||
Common Stock Shares Issued | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | 24 | |||||
Shares Outstanding | 23 | 23 | 23 | - | - | - | 23 | - | - | - | - | - | |||||
Treasury Stock Common Shares | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | |||||
Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables
Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables
Custom Table
Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals
Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals
Interactive Financial Visualizations
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Earnings Market Reaction
| Fiscal Year | Q1 1 Month | Q1 2 Month | Q1 3 Month | Q2 1 Month | Q2 2 Month | Q2 3 Month | Q3 1 Month | Q3 2 Month | Q3 3 Month | Q4 1 Month | Q4 2 Month | Q4 3 Month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -13.91% | -13.00% | -13.06% | - | - | - | - | - | - | - | - | - |
| 2025 | 1.10% | 1.56% | 1.39% | 2.51% | -9.51% | -4.11% | -4.24% | -3.28% | -2.77% | -6.28% | 0.82% | -14.21% |
| 2024 | 3.83% | 8.30% | 12.97% | 9.09% | 10.80% | 3.47% | 2.79% | -10.81% | -6.92% | -8.88% | -5.83% | -7.26% |
| 2023 | - | - | - | 2.12% | -4.37% | -16.80% | 9.04% | 14.98% | 14.69% | -4.86% | -9.41% | 12.57% |
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial | ||||||||||||
Subscribe to unlock 17+ years of financial data and 90+ calculated metrics
Subscribe to unlock 17+ years of data and 90+ calculated metrics
Performance and Valuation Metrics
Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.
Metrics | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | Subscriber-only column | Subscriber-only column | Subscriber-only column | Subscriber-only column | Metric history beyond 3 years is for subscribers only. Unlock 17+ years of history across 90+ calculated metrics Start 7-day free trial |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Liquidity Ratios | |||||||||||||||||
| Current Ratio | 16.31 | 14.32 | 12.89 | 13.58 | 13.96 | 16.49 | 13.14 | 7.74 | 8.36 | 7.57 | 6.51 | 6.28 | |||||
| Quick Ratio | 16.12 | 14.20 | 12.75 | 13.41 | 13.77 | 16.31 | 12.90 | 7.54 | 8.16 | 7.43 | 6.30 | 6.10 | |||||
| Working Capital | 458.36M | 444.45M | 431.91M | 418.74M | 399.31M | 383.37M | 371.59M | 197.77M | 187.37M | 176.15M | 164.72M | 153.16M | |||||
Leverage & Debt | |||||||||||||||||
| Debt to Equity | 0.52 | 0.55 | 0.56 | 0.58 | 0.59 | 0.60 | 0.64 | 0.14 | 0.14 | 0.15 | 0.16 | 0.16 | |||||
| Interest Coverage TTM | 14.88 | 14.07 | 13.10 | 15.14 | 19.60 | 35.46 | 254.91 | - | - | - | - | - | |||||
| Debt Ratio | 0.34 | 0.35 | 0.36 | 0.37 | 0.37 | 0.37 | 0.39 | 0.12 | 0.12 | 0.13 | 0.14 | 0.14 | |||||
Efficiency & Turnover | |||||||||||||||||
| Asset Turnover TTM | 0.43 | 0.43 | 0.43 | 0.49 | 0.50 | 0.50 | 0.49 | 0.60 | 0.60 | 0.60 | 0.59 | 0.58 | |||||
| Days Sales Outstanding TTM | 50.22 | 50.48 | 46.56 | 49.01 | 52.39 | 52.71 | 45.76 | 48.10 | 50.79 | 50.76 | 44.43 | 43.25 | |||||
| Receivables Turnover TTM | 7.27 | 7.23 | 7.84 | 7.45 | 6.97 | 6.92 | 7.98 | 7.59 | 7.19 | 7.19 | 8.22 | 8.44 | |||||
Per Share Metrics | |||||||||||||||||
| Diluted EPS TTM | 2.68 | 2.71 | 2.52 | 2.19 | 2.06 | 1.97 | 1.93 | 1.81 | 1.66 | 1.50 | 1.34 | 1.21 | |||||
| Free Cash Flow Per Share TTM | 3.23 | 3.47 | 3.29 | 2.92 | 2.31 | 1.82 | 1.66 | 1.49 | 1.41 | 1.48 | 1.33 | 1.03 | |||||
| Dividend Per Share TTM | 0.90 | 0.85 | 0.80 | 0.76 | 0.72 | 0.68 | 0.64 | 0.62 | 0.60 | 0.58 | 0.56 | 0.54 | |||||
Margin Metrics | |||||||||||||||||
| Gross Profit Margin TTM | 72.90% | 72.39% | 71.53% | 70.97% | 69.11% | 68.80% | 68.63% | 68.34% | 67.70% | 66.45% | 65.66% | 64.58% | |||||
| Operating Profit Margin TTM | 29.46% | 28.51% | 27.21% | 25.71% | 23.34% | 23.43% | 23.77% | 23.29% | 22.20% | 20.37% | 18.97% | 18.04% | |||||
| Net Profit Margin TTM | 25.02% | 24.35% | 23.13% | 22.14% | 20.08% | 19.96% | 20.03% | 19.40% | 18.32% | 16.99% | 15.56% | 14.69% | |||||
Growth Metrics | |||||||||||||||||
| Net Revenue Growth (1Y) | 11.85% | 13.27% | 13.53% | 13.07% | 14.11% | 13.19% | 13.63% | 14.81% | 16.06% | 18.16% | 19.69% | 15.83% | |||||
| Net Income Growth (1Y) | 39.39% | 38.17% | 31.10% | 29.08% | 25.04% | 33.02% | 46.28% | 51.53% | 49.40% | 64.51% | 45.89% | 28.72% | |||||
| EPS Growth (1Y) | 37.90% | 36.77% | 30.02% | 28.04% | 24.18% | 31.81% | 44.75% | 50.10% | 47.77% | 62.64% | 44.30% | 27.10% | |||||
Valuation Metrics | |||||||||||||||||
| P/E TTM | 33.30 | 39.67 | 31.55 | 36.81 | 39.38 | 41.32 | 46.18 | 49.60 | 48.04 | 42.74 | 40.85 | 43.27 | |||||
| P/B TTM | 5.20 | 6.09 | 4.63 | 5.18 | 5.12 | 5.37 | 6.03 | 6.19 | 5.67 | 4.70 | 4.13 | 4.09 | |||||
| P/S TTM | 8.33 | 9.66 | 7.30 | 8.15 | 7.91 | 8.25 | 9.25 | 9.62 | 8.80 | 7.26 | 6.36 | 6.36 | |||||
| Market Cap | 2.19B | 2.48B | 1.82B | 1.96B | 1.86B | 1.87B | 2.03B | 2.05B | 1.81B | 1.45B | 1.23B | 1.18B | |||||
| Enterprise Value | 2.33B | 2.62B | 1.96B | 2.11B | 2.00B | 2.01B | 2.18B | 2.03B | 1.79B | 1.42B | 1.21B | 1.16B | |||||
Calculated Values | |||||||||||||||||
| Free Cash Flow TTM | 73.83M | 79.12M | 74.47M | 66.23M | 52.32M | 41.12M | 37.16M | 33.49M | 31.69M | 33.04M | 29.49M | 22.84M | |||||
| Net Debt | 142.47M | 142.02M | 140.40M | 142.93M | 141.03M | 142.64M | 142.16M | -21.00M | -22.27M | -26.60M | -24.27M | -18.05M | |||||
Per-Share and Margin | |||||||||||||||||
| EPS TTM | |||||||||||||||||
| Adjusted EPS TTM | |||||||||||||||||
| Cash Flow Per Share TTM | |||||||||||||||||
| Pretax Margin TTM | |||||||||||||||||
| Stock Comp to Revenue TTM | |||||||||||||||||
Turnover Ratios and Averages | |||||||||||||||||
| Average Assets | |||||||||||||||||
| Average Equity | |||||||||||||||||
| Average Inventory | |||||||||||||||||
| Average Receivables | |||||||||||||||||
| Average Accounts Payables | |||||||||||||||||
| Inventory Turnover TTM | |||||||||||||||||
| Payables Turnover TTM | |||||||||||||||||
| Days Inventory Outstanding TTM | |||||||||||||||||
| Days Payables Outstanding TTM | |||||||||||||||||
| Cash Conversion Cycle TTM | |||||||||||||||||
| Working Capital to Revenue | |||||||||||||||||
| Deferred Revenue to Revenue | |||||||||||||||||
Growth Rates | |||||||||||||||||
| Total Assets Growth (1Y) | |||||||||||||||||
| Total Assets Growth (3Y) | |||||||||||||||||
| Total Assets Growth (5Y) | |||||||||||||||||
| Dividends Paid Growth (1Y) | |||||||||||||||||
| Dividends Paid Growth (3Y) | |||||||||||||||||
| Dividends Paid Growth (5Y) | |||||||||||||||||
| EPS Growth (3Y) | |||||||||||||||||
| EPS Growth (5Y) | |||||||||||||||||
| Net Income Growth (3Y) | |||||||||||||||||
| Net Income Growth (5Y) | |||||||||||||||||
| Net Profit Margin Growth (1Y) | |||||||||||||||||
| Net Profit Margin Growth (3Y) | |||||||||||||||||
| Net Profit Margin Growth (5Y) | |||||||||||||||||
| Net Revenue Growth (3Y) | |||||||||||||||||
| Net Revenue Growth (5Y) | |||||||||||||||||
| Deferred Revenue Growth (1Y) | |||||||||||||||||
| Retained Earnings Growth (1Y) | |||||||||||||||||
Credit, Liquidity, Returns, Payout | |||||||||||||||||
| Cash Ratio | |||||||||||||||||
| Net Working Capital | |||||||||||||||||
| Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to EBITDA TTM | |||||||||||||||||
| Net Debt to Equity | |||||||||||||||||
| Altman A | |||||||||||||||||
| Altman B | |||||||||||||||||
| Altman C | |||||||||||||||||
| Altman D | |||||||||||||||||
| Altman E | |||||||||||||||||
| Altman Z-Score | |||||||||||||||||
| ROA TTM | |||||||||||||||||
| ROE TTM | |||||||||||||||||
| NOPAT TTM | |||||||||||||||||
| ROIC TTM | |||||||||||||||||
| Effective Tax Rate TTM | |||||||||||||||||
| Payout Ratio TTM | |||||||||||||||||
| Dilution Ratio | |||||||||||||||||
| Retained Earnings to Equity | |||||||||||||||||
| Treasury Stock to Equity | |||||||||||||||||
| Treasury Stock Change (1Y) | |||||||||||||||||
| Accrued to Current Liabilities | |||||||||||||||||
| NCAV | |||||||||||||||||
| NCAV Per Share TTM | |||||||||||||||||
Valuation Ratios | |||||||||||||||||
| P/CF TTM | |||||||||||||||||
| PEG Ratio | |||||||||||||||||
| Dividend Yield TTM | |||||||||||||||||
| Free Cash Flow Yield TTM | |||||||||||||||||
| EV EBITDA TTM | |||||||||||||||||
| EV EBIT TTM | |||||||||||||||||
| EV Revenue TTM | |||||||||||||||||
| EV FCF TTM | |||||||||||||||||
| Stock Compensation TTM | |||||||||||||||||
| Adjusted Net Income TTM | |||||||||||||||||
| Billings TTM | |||||||||||||||||
| Total Debt | |||||||||||||||||
| Invested Capital | |||||||||||||||||
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Insider Transactions
Subscribe to unlock 17+ years of financial data
Subscribe to unlock 17+ years of data
Institutional Ownership
LEMAITRE VASCULAR INC (LMAT) — SEC Financial Statements & Analysis
LEMAITRE VASCULAR INC (LMAT) is a surgical & medical instruments & apparatus company. LEMAITRE VASCULAR INC trades on Nasdaq as: LMAT. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), LEMAITRE VASCULAR INC reported a 11.85% year-over-year revenue growth, a Gross Profit Margin of 72.90% (TTM), a Debt-to-Equity ratio of 0.52x, a Price-to-Sales (P/S) ratio of 8.33x (TTM), a Price-to-Book (P/B) ratio of 5.20x (TTM), at a market cap of $2.19B. Figures below are sourced from SEC EDGAR, as-filed.
- Net Revenue TTM Growth 1Y
- 11.85%
- Gross Profit Margin TTM
- 72.90%
- Debt To Equity
- 0.52x
- P/S TTM
- 8.33x
- P/B TTM
- 5.20x
- Market Cap
- $2.19B
Data as of 2026-06-30 · Source: SEC EDGAR
Frequently Asked Questions
What industry is LEMAITRE VASCULAR INC in?
LEMAITRE VASCULAR INC (LMAT) operates in the Surgical & Medical Instruments & Apparatus industry.
What is LMAT's market cap?
LEMAITRE VASCULAR INC (LMAT) has a market capitalization of $2.19B as of 2026-06-30.
What is LMAT's P/E ratio?
LEMAITRE VASCULAR INC (LMAT)'s trailing twelve month P/E ratio is 33.30x as of 2026-06-30.
What exchange does LMAT trade on?
LEMAITRE VASCULAR INC (LMAT) trades on the Nasdaq.